The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Interneurons from Embryonic Development to Cell-Based Therapy
Open accessAbstract
Background: Alterations in neural excitation and inhibition cause a number of neurologic and psychiatric disorders. In the cerebral cortex, excitation and inhibition are mediated by two cell types born in distinct areas of the embryo: excitatory projection neurons, which are generated in the developing cortex, and inhibitory interneurons, which are produced outside the cortex in the ventral forebrain. After migrating from their origins across the developing brain, young interneurons reach the cortex and differentiate into various inhibitory neuronal cell types. Roughly two-thirds of these young cells survive in the cortex to form the local inhibitory circuits that shape excitatory neuron activity. The embryologic programs that guide interneuron migration, survival, and circuit integration are also executed by these young neurons after their transplantation into the juvenile and adult nervous systems. These processes, realized in the developmentally and topographically distinct environment of the recipient, offer a unique opportunity for studying neurodevelopment and therapeutically modifying neural circuits. Advances: In both neonatal and adult rodents, transplanted embryonic interneurons have been shown to migrate and survive in diverse neural structures, including the cerebral cortex and the spinal cord. Transplanted interneurons form elaborate processes in host tissues, receive synaptic inputs, and make inhibitory connections with host neurons, similar to what they do in their normal setting. Functionally, transplantation has been used to modify inhibitory signaling in the host brain and to induce reorganization of the cortex by creating new windows of neural circuit plasticity. Transplanted interneurons have been shown to modify disease phenotypes in several rodent models of neurologic and psychiatric disorders, including epilepsy, chronic pain, Parkinson’s disease, schizophrenia, and anxiety. Interneuron transplantation has also been used to explore how cell-intrinsic and environmental factors interact to govern cellular fate and circuit formation. To generate interneurons for possible clinical applications, researchers are developing in vitro culture systems for the derivation of interneurons from embryonic stem cells and induced pluripotent stem cells. These efforts have produced new interneurons that, like their endogenous counterparts, disperse and integrate in the recipient brain after transplantation. Outlook: Cortical interneurons are a heterogeneous population, and little is known about how distinct subtypes of interneurons function in neural circuits. Thus far, transplantation studies have used donor pools containing large mixtures of interneurons. As the mechanisms underlying interneuron diversity become better understood, donor populations may be selected or produced to include only specific subtypes of cells. This will allow researchers to study the functional roles of different interneuron types and may permit the use of specific donor populations for different pathologies. It is unknown how transplanted interneurons modify disease phenotypes. While transplanted interneurons likely exert therapeutic effects by increasing neural inhibition, other mechanisms are also possible. By transplanting mutant cells, or cells engineered to respond to optogenetic or chemical stimulation, these mechanisms may be elucidated. Eventual clinical applications will require more subtle and detailed studies of the behavioral effects of interneuron transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954
Model of autism: increased ratio of excitation/inhibition in key neural systems
Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768
Self-citationCritical period plasticity in local cortical circuits
Hensch, T. K. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1787 · Cited by 2,323 · cited 3×
“During a critical period that occurs in late postnatal life, rodent ocular dominance plasticity is transiently heightened, presumably because of the maturation of cortical inhibition in the visual cortex (54).”
BackgroundCortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Reactivation of Ocular Dominance Plasticity in the Adult Visual Cortex
Pizzorusso, T., Medini, P., Berardi, N., Chierzi, S., Fawcett, J. W., & Maffei, L. (2002) · Science · doi:10.1126/science.1072699 · Cited by 1,679
Verret, L., Mann, E. O., Hang, G. B., Barth, A. M. I., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A. C., Mody, I., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.046 · Cited by 1,216
Interneuron dysfunction in psychiatric disorders
Marín, O. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3155 · Cited by 1,190
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H.-C., Heintz, N., et al. (2010) · Nature · doi:10.1038/nature09582 · Cited by 1,168
Self-citation
Cited by
Network abnormalities and interneuron dysfunction in Alzheimer disease
Palop, J. J., & Mucke, L. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.141 · Cited by 1,022
The Cellular and Molecular Landscapes of the Developing Human Central Nervous System
Silbereis, J. C., Pochareddy, S., Zhu, Y., Li, M., & Sestan, N. (2016) · Neuron · doi:10.1016/j.neuron.2015.12.008 · Cited by 818
Molecular mechanisms of epilepsy
Staley, K. (2015) · Nature Neuroscience · doi:10.1038/nn.3947 · Cited by 376
Bi, D., Wen, L., Wu, Z., & Shen, Y. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12088 · Cited by 232
Cunningham, M., Cho, J.-H., Leung, A., Savvidis, G., Ahn, S., Moon, M., Lee, P. K. J., Han, J. J., Azimi, N., Kim, K.-S., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.10.006 · Cited by 218
Metadata
- Authors
- Southwell, D. G., Nicholas, C. R., Basbaum, A. I., Stryker, M. P., Kriegstein, A. R., Rubenstein, J. L., & Alvarez-Buylla, A.
- Venue
- Science
- Published
- 2014-04-11
- Volume
- 344
- Issue
- 6180
- Pages
- 1240622-1240622
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1967100899
- Cited by
- 189
- References
- 21
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interneurons from Embryonic Development to Cell-Based Therapy. https://app.cochat.ai/papers/10.1126/science.1240622
- The paper
- Southwell, D. G., Nicholas, C. R., Basbaum, A. I., Stryker, M. P., Kriegstein, A. R., Rubenstein, J. L., & Alvarez-Buylla, A. (2014). Interneurons from Embryonic Development to Cell-Based Therapy. Science. https://doi.org/10.1126/science.1240622
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.